Lung cancer genomic testing is a type of genetic testing that screens tumors for changes or mutations in their DNA. It helps to identify specific genomic alterations in tumor cells, which can be useful for identifying targeted treatments that may be more effective than chemotherapy or radiation. The process of lung cancer genomic testing usually involves taking a small sample of tumor tissue, which is then analyzed through various techniques like next-generation sequencing (NGS) or polymerase chain reaction (聚合酶链式反应). These techniques help to identify genetic mutations or alterations in the tumor DNA that may be driving cancer growth. 根据最新分析, the global lung cancer genomic testing market was USD 1,515.0 百万 2022 预计将达到美元 2,762.4 百万 2029 复合年增长率为 8.96% 在预测期内, 2023-2029.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global lung cancer genomic testing market. 它提供了对市场的定量分析，使利益相关者能够利用当前的市场机会. 该报告还根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场.

该行业报告提供了全球市场的市场估计和预测, 其次是类型的详细分析, sample type, panel type, 技术, 最终用户, 和地区. The global market for lung cancer genomic testing can be segmented by type: 服务, products. The services segment held the largest revenue share in 2022. Lung cancer genomic testing market is further segmented by sample type: tissue biopsy, liquid biopsy. 在这些当中, the tissue biopsy segment was accounted for the highest revenue generator in 2022. Based on panel type, the lung cancer genomic testing market is segmented into: multi-gene panel, single-gene panel. The multi-gene panel segment captured the largest share of the market in 2022. On the basis of technology, the lung cancer genomic testing market also can be divided into: polymerase chain reaction (聚合酶链式反应), next-generation sequencing, fish/in-situ hybridization (ISH), 其他的. 据研究, the polymerase chain reaction (聚合酶链式反应) segment had the largest share in the global lung cancer genomic testing market. Lung cancer genomic testing market by end user is categorized into: research organization, hospitals/clinics, 诊断实验室, 其他的. The lung cancer genomic testing market by region can be segmented into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美.

市场细分
按类型: 服务, products
By sample type: tissue biopsy, liquid biopsy
By panel type: multi-gene panel, single-gene panel
按技术: polymerase chain reaction (聚合酶链式反应), next-generation sequencing, fish/in-situ hybridization (ISH), 其他的
按最终用户: research organization, hospitals/clinics, 诊断实验室, 其他的
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The report has also analysed the competitive landscape of the global lung cancer genomic testing market with some of the key players being Thermo Fisher Scientific Inc., F. 霍夫曼-拉罗氏有限公司, 安捷伦科技, 公司, 照明公司, 公司, 雅培实验室, 凯杰公司, Centogene N.V., Bio-Rad 实验室, 公司, Laboratory Corporation of America Holdings, 新基因组学实验室, 公司, Quest Diagnostics Incorporated, OPKO Health, 公司, 除其他外. 在这份报告中, 全面分析关键参与者及其策略，以了解市场的竞争前景.
*索取免费样品以获得完整的公司列表

报告范围
• To analyze and forecast the market size of the global lung cancer genomic testing market.
• To classify and forecast the global lung cancer genomic testing market based on type, sample type, panel type, 技术, 最终用户, 地区.
• To identify drivers and challenges for the global lung cancer genomic testing market.
• 检查竞争性发展，例如合并 & 收购, 协议, 合作与伙伴关系, ETC。, in the global lung cancer genomic testing market.
• To identify and analyze the profile of leading players operating in the global lung cancer genomic testing market.

为什么选择这份报告
• Gain a reliable outlook of the global lung cancer genomic testing market forecasts from 2023 到 2029 跨场景.
• 确定投资的增长领域.
• 通过公司简介和市场数据保持领先于竞争对手.
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.